Lv1
40 积分 2025-10-10 加入
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
5天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
10天前
已完结
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
21天前
已完结
Unlocking the potential of T cell engagers in solid tumors
26天前
已完结
High expression of ALPPL2 is associated with poor prognosis in gastric cancer
28天前
已完结
Mechanism of Thrombocytopenia Induced by Anti-CD40 Ligand Immune Complexes and the Prevalence of CD40 Ligand Autoantibodies in Patients with Thrombotic Autoimmune Disorders
3个月前
已关闭
Bispecific T cell engager therapy for refractory rheumatoid arthritis
7个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
8个月前
已完结
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
8个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
8个月前
已完结
皖公网安备34019202002308
